Hatay Pharmaceutical profit drops 16.65% in first half

Hatay Pharmaceutical Joint Stock Company reported a profit after tax of VND 28,612,987,213 for the first half of 2025, marking a 16.65% decrease from VND 34,327,930,350 in the same period of 2024. This decline is primarily attributed to increased general and administrative expenses, which rose by 23.86% to VND 57,414,106,905 from VND 46,353,637,140 in 2024.

Additionally, finance costs contributed to the profit reduction, increasing by 13.94% to VND 13,245,813,064 in the first six months of 2025, up from VND 11,625,076,116 in 2024. This rise was largely due to fluctuations in foreign exchange rates during the period. The company's total assets as of June 30, 2025, stood at VND 1,943,336,705,238, an increase from VND 1,870,077,300,638 at the beginning of the year.

The company's management will hold an extraordinary general meeting of shareholders in 2025 to approve the issuance of bonus shares to existing shareholders at a rate of 10% from the company's share premium and profits, as approved by the board of directors on July 24, 2025.